Soleus Capital Management »

Avalyn Pharma shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Avalyn Pharma shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Avalyn Pharma

Tip: Access up to 7 years of quarterly data

All positions including Avalyn Pharma held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalyn Pharma by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $14M 419k 32.92

More positions owned by Soleus Capital Management

Krystal Biotech (KRYS)
Celcuity (CELC)
Tg Therapeutics (TGTX)
Insulet Corporation (PODD)
Novocure Ord Shs (NVCR)
United Therapeutics Corporation (UTHR)
Inspire Med Sys (INSP)
Rigel Pharmaceuticals (RIGL)
Biosante Pharmaceuticals (ANIP)
Beta Bionics (BBNX)
Vericel (VCEL)
Praxis Precision Medicines I Com New (PRAX)
Geron Corporation (GERN)
Alkermes SHS (ALKS)
Erasca (ERAS)

View all positions for Soleus Capital Management

Top funds holding Avalyn Pharma

Sr One Capital Management
NVP Associates
Pivotal bioVenture Partners Investment Advisor
Vanguard Capital Management
Soleus Capital Management
Federated Investors
Vanguard Portfolio Management
Vanguard Fiduciary Trust
TD Asset Management
Standard Life Aberdeen
Bank of New York Mellon
Vanguard Global Advisers
Jpmorgan Chase & Co
New York State Common Retirement Fund
OTR - Nominee Name for The State Teachers Retirement Board of Ohio

View all funds holding Avalyn Pharma